Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 2,045,500 | 1,899,600 | 1,678,600 | 1,447,000 | 1,321,400 |
| Cost of Goods | 516,600 | 491,000 | 489,800 | 408,300 | 399,100 |
| Gross Profit | 1,528,900 | 1,408,600 | 1,188,800 | 1,038,700 | 922,300 |
| Operating Expenses | 1,057,000 | 988,700 | 889,500 | 754,700 | 684,400 |
| Operating Income | 472,500 | 419,900 | 300,100 | 284,300 | 238,000 |
| Interest Expense | 9,800 | 4,400 | 3,100 | 2,400 | 2,700 |
| Other Income | 48,500 | -27,300 | -13,400 | -13,700 | 69,100 |
| Pre-tax Income | 511,200 | 388,200 | 283,600 | 268,200 | 304,400 |
| Income Tax | 122,100 | 96,700 | 46,900 | 50,200 | 75,300 |
| Net Income Continuous | 389,100 | 291,500 | 236,700 | 218,000 | 229,100 |
| Net Income | $389,100 | $291,500 | $236,700 | $218,000 | $229,100 |
| EPS Basic Total Ops | 0.58 | 0.42 | 0.35 | 0.32 | 0.34 |
| EPS Basic Continuous Ops | 0.58 | 0.42 | 0.34 | 0.32 | 0.34 |
| EPS Diluted Total Ops | 0.57 | 0.41 | 0.33 | 0.31 | 0.33 |
| EPS Diluted Continuous Ops | 0.57 | 0.41 | 0.33 | 0.30 | 0.33 |
| EBITDA(a) | $535,400 | $473,600 | $358,100 | $340,800 | $296,700 |